Founder of GitLab battles cancer by founding companies
GitLab founder Sytse Sijbrandij is battling an aggressive bone cancer by transforming his personal health crisis into an entrepreneurial and data-driven mission. He's leveraging his significant resources to pursue novel, highly personalized treatments, open-sourcing his data, and founding new ventures in the process. This incredible display of agency and resourcefulness resonates deeply on HN, sparking discussions about healthcare innovation, wealth disparity, and the limits of traditional medicine.
The Lowdown
Sytse Sijbrandij, the founder of GitLab, faces a daunting diagnosis of osteosarcoma in his T5 vertebrae. After exhausting standard medical care and finding no suitable clinical trials, he has adopted an extraordinary entrepreneurial approach to his own treatment.
- He's employing 'maximum diagnostics' and developing new, personalized treatment protocols, often pursuing multiple therapies in parallel.
- Sijbrandij is actively working to 'scale this for others,' suggesting his personal battle aims to catalyze broader innovation in cancer treatment.
- He openly shares his extensive data, treatment timeline, and insights on osteosarc.com, including 25TB of publicly readable Google Cloud data.
- He advocates for a 'patient-first' medical industry, criticizing existing bureaucracy.
Sijbrandij's journey exemplifies applying a founder's mindset to life's most challenging battles, turning a personal health crisis into a transparent, data-driven quest that seeks to push the boundaries of conventional medicine for himself and potentially, for others.
The Gossip
Entrepreneurial Endeavor Against Illness
Many commenters expressed profound admiration for Sytse Sijbrandij's remarkable resilience and proactive, entrepreneurial spirit in the face of a terminal illness. They highlighted his refusal to 'slow down,' leveraging his business acumen and inspiring 'will to live' to innovate his own treatment and even found companies, viewing his approach as a testament to human agency.
Dollars and Diagnostics: The Wealth Divide in Wellness
A significant portion of the discussion centered on the role of Sijbrandij's substantial wealth and access in enabling his unconventional treatment path. While some acknowledge that such resources are a prerequisite for this level of personalized care, others debate whether this is a positive example of individual innovation or a stark reminder of healthcare inequality. The precise definition of 'unfathomable wealth' also became a point of contention among users.
Medical Monoliths and Mitochondrial Miracles
Several commenters voiced frustration with the perceived rigidity, 'legacy thinking,' and bureaucracy within the standard medical system for cancer treatment, suggesting it often misses opportunities for more effective or personalized care. This led to discussions about alternative theories, such as the metabolic theory of cancer, and specific treatments like desloratadine, with some debating the testability and scientific validity of these less conventional approaches.